Ginny Blocki
Vertrieb & Marketing bei EMBECTA CORP.
Aktive Positionen von Ginny Blocki
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EMBECTA CORP. | Vertrieb & Marketing | 22.03.2022 | - |
Karriereverlauf von Ginny Blocki
Ehemalige bekannte Positionen von Ginny Blocki
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BECTON, DICKINSON AND COMPANY | Vertrieb & Marketing | 01.10.2021 | 01.03.2022 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.06.2020 | 01.10.2021 |
| BAXALTA INC | Vertrieb & Marketing | - | - |
| ABBOTT LABORATORIES | Vertrieb & Marketing | - | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Corporate Officer/Principal | - | - |
Ausbildung von Ginny Blocki
| Indiana University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Sales & Marketing | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| EMBECTA CORP. | Health Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
- Börse
- Insiders
- Ginny Blocki
- Erfahrung